Stock listing

GLMD Stock Price, News, Filings & Events — Galmed Pharmaceuticals Ltd.

Selected listing: GLMD · NASDAQ · USD · US

This page tracks Galmed Pharmaceuticals Ltd.'s GLMD:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GLMD:NASDAQ. GLMD:NASDAQ is the stock-level entry point for investors researching Galmed Pharmaceuticals Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Galmed Pharmaceuticals Ltd. (Ticker: GLMD) is a public company operating in the American market. The company has a market capitalization of approximately $4.24 million. Galmed focuses on developing innovative therapies for liver diseases and other metabolic disorders.

GLMD:NASDAQUSDUSUpdated July 31, 2026
Galmed Pharmaceuticals Ltd. logo
Ticker
GLMD:NASDAQ
Asset type
Stock
Market cap
$5.1M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD

Galmed Pharmaceuticals Ltd. GLMD:NASDAQ stock context

This page tracks Galmed Pharmaceuticals Ltd.'s GLMD:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GLMD:NASDAQ. GLMD:NASDAQ is the stock-level entry point for investors researching Galmed Pharmaceuticals Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Galmed Pharmaceuticals Ltd. (Ticker: GLMD) is a public company operating in the American market. The company has a market capitalization of approximately $4.24 million. Galmed focuses on developing innovative therapies for liver diseases and other metabolic disorders.

Research Galmed Pharmaceuticals Ltd.

Alternate listings